BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis (Q29617585)
scientific article (publication date: October 2004)
Language:
(P31) (Q13442814)
(P304) 7099-109
(P407) (Q1860)
(P433) 19
(P478) 64
(P577) Friday, October 1, 2004
(P921) (Q539568)
(Q16909647)
(P1433) (Q326097)
(P1476) "BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis" (language: en)
(P2093) Wilhelm SM
Carter C
Tang L
Wilkie D
McNabola A
Rong H
Chen C
Zhang X
Vincent P
McHugh M
Cao Y
Shujath J
Gawlak S
Eveleigh D
Rowley B
Liu L
Adnane L
Lynch M
Auclair D
Taylor I
Gedrich R
Voznesensky A
Riedl B
Post LE
Bollag G
Trail PA
(P2860) (Q27860760)
other details
description scientific article (publication date: October 2004)

External Links